"Roche Holding AG posted flat sales for the first nine months of 2014, but the results show strong demand for its cancer drugs and new products, the Swiss drug maker said Thursday. Roche noted that a number of currencies, notably the US dollar, remained weaker against the Swiss franc throughout the year."
That is what happens when you print too many of them to keep the wealthy afloat.
